Stock Scorer

Celularity Inc (CELU)

Celularity Inc reported revenue of 4.1M USD for the quarter ending 31 December 2025, down 77.4% from 18.1M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q4 '25 · ending 31 December 2025 4.1M -77.4%
Gross Profit Q4 '23 · ending 31 December 2023 2.5M —
Operating Income Q4 '25 · ending 31 December 2025 -22.1M —
Net Income Q4 '25 · ending 31 December 2025 -24.4M —
Cost of Revenue Q4 '25 · ending 31 December 2025 7.4M +0.4%
Operating Cash Flow Q4 '25 · ending 31 December 2025 -5.1M -420.1%
Free Cash Flow Q4 '24 · ending 31 December 2024 1.5M —
Shares Outstanding Q3 '25 · ending 30 September 2025 26.3M +20.6%
EPS Q4 '25 · ending 31 December 2025 -3.59 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 26.6M-61.3M-91.7M—
20242024-12-31 54.2M-38.4M-57.9M-6.6M
20232023-12-31 22.8M-192.3M-196.3M-39.7M
20222022-12-31 18M-25.6M14.2M-143.1M
20212021-12-31 21.3M-109.1M-100.1M-116.3M
20202020-12-31 14.3M-151.9M-208.2M-91M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q4 '252025-12-314.1M
Q3 '252025-09-305.3M
Q2 '252025-06-305.7M
Q1 '252025-03-3111.4M
Q4 '242024-12-3118.1M
Q3 '242024-09-309.3M
Q2 '242024-06-3012.1M
Q1 '242024-03-3114.7M
Q4 '232023-12-3112.1M
Q3 '232023-09-303.8M
Q2 '232023-06-302.9M
Q1 '232023-03-313.9M
Q4 '222022-12-314.1M
Q3 '222022-09-304.1M
Q2 '222022-06-303.8M
Q1 '222022-03-315.9M
Q4 '212021-12-314.9M
Q3 '212021-09-3010.6M
Q2 '212021-06-303.2M
Q1 '212021-03-312.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q4 '232023-12-312.5M
Q3 '232023-09-30184K
Q2 '232023-06-302.1M
Q1 '232023-03-311.9M
Q4 '222022-12-31-1.1M
Q3 '222022-09-30-3.1M
Q2 '222022-06-30597K
Q1 '222022-03-311.9M
Q4 '212021-12-31196K
Q3 '212021-09-308.3M
Q2 '212021-06-301.8M
Q1 '212021-03-311.4M
Q4 '202020-12-312.1M
Q3 '202020-09-302.3M

Operating Income Quarterly

PeriodEndingOperating Income
Q4 '252025-12-31-22.1M
Q3 '252025-09-30-12.9M
Q2 '252025-06-30-15.9M
Q1 '252025-03-31-10.5M
Q4 '242024-12-31-9.3M
Q3 '242024-09-30-11.5M
Q2 '242024-06-30-10.2M
Q1 '242024-03-31-7.4M
Q4 '232023-12-3113.3M
Q3 '232023-09-30-99.3M
Q2 '232023-06-30-42.5M
Q1 '232023-03-31-63.9M
Q4 '222022-12-3117.5M
Q3 '222022-09-30-5.6M
Q2 '222022-06-304.2M
Q1 '222022-03-31-41.6M
Q4 '212021-12-31-15M
Q3 '212021-09-3010.9M
Q2 '212021-06-30-60.6M
Q1 '212021-03-31-44.4M

Net Income Quarterly

PeriodEndingNet Income
Q4 '252025-12-31-24.4M
Q3 '252025-09-30-23.1M
Q2 '252025-06-30-24.5M
Q1 '252025-03-31-19.8M
Q4 '242024-12-31-13.3M
Q3 '242024-09-30-16.1M
Q2 '242024-06-30-6.5M
Q1 '242024-03-31-22M
Q4 '232023-12-319.5M
Q3 '232023-09-30-93.9M
Q2 '232023-06-30-47.9M
Q1 '232023-03-31-64M
Q4 '222022-12-3124.4M
Q3 '222022-09-304.8M
Q2 '222022-06-3047.8M
Q1 '222022-03-31-62.9M
Q4 '212021-12-31-4M
Q3 '212021-09-3049.9M
Q2 '212021-06-30-64.5M
Q1 '212021-03-31-81.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q4 '252025-12-317.4M
Q3 '252025-09-303.9M
Q2 '252025-06-305.2M
Q1 '252025-03-313.6M
Q4 '242024-12-317.3M
Q3 '242024-09-303.9M
Q2 '242024-06-302.1M
Q1 '242024-03-311.6M
Q4 '232023-12-319.6M
Q3 '232023-09-303.6M
Q2 '232023-06-30802K
Q1 '232023-03-312M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q4 '252025-12-31-5.1M
Q3 '252025-09-30-4.2M
Q2 '252025-06-30-999K
Q1 '252025-03-31-3M
Q4 '242024-12-311.6M
Q3 '242024-09-30-144K
Q2 '242024-06-30-3.4M
Q1 '242024-03-31-4.4M
Q4 '232023-12-31-4.3M
Q3 '232023-09-30-8.3M
Q2 '232023-06-30-11M
Q1 '232023-03-31-15M
Q4 '222022-12-31-29.6M
Q3 '222022-09-30-37.7M
Q2 '222022-06-30-36.3M
Q1 '222022-03-31-34.3M
Q4 '212021-12-31-32M
Q3 '212021-09-30-34.8M
Q2 '212021-06-30-18.2M
Q1 '212021-03-31-25.1M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '242024-12-311.5M
Q3 '242024-09-30-144K
Q2 '242024-06-30-3.5M
Q1 '242024-03-31-4.4M
Q4 '232023-12-31-4.9M
Q3 '232023-09-30-8.6M
Q2 '232023-06-30-11.1M
Q1 '232023-03-31-15.2M
Q4 '222022-12-31-30.4M
Q3 '222022-09-30-39.3M
Q2 '222022-06-30-37.8M
Q1 '222022-03-31-35.7M
Q4 '212021-12-31-34.3M
Q3 '212021-09-30-35.9M
Q2 '212021-06-30-19.5M
Q1 '212021-03-31-26.6M
Q4 '202020-12-31-26.2M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q3 '252025-09-3026.3M
Q2 '252025-06-3024M
Q1 '252025-03-3123.5M
Q3 '242024-09-3022M
Q2 '242024-06-3021.8M
Q1 '242024-03-3121.4M
Q3 '232023-09-3018.8M
Q2 '232023-06-3017.7M
Q1 '232023-03-3115.5M
Q3 '222022-09-30150.5M
Q2 '222022-06-30151.3M
Q1 '222022-03-31130.4M
Q3 '212021-09-30123.6M
Q2 '212021-06-3024M
Q3 '202020-09-3018.4M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q4 '252025-12-31-3.59
Q3 '252025-09-30-3.33
Q2 '252025-06-30-3.18
Q1 '252025-03-31-2.46
Q4 '242024-12-31-2.65
Q3 '242024-09-30-1.26
Q2 '242024-06-30-5.51
Q1 '242024-03-31-7.93
Q4 '232023-12-31-11.02
Q3 '232023-09-30-10.80
Q2 '232023-06-30-5.79
Q1 '232023-03-31-2.75
Q4 '222022-12-310.89
Q3 '222022-09-304.07
Q2 '222022-06-304.44
Q1 '222022-03-311.43
Q4 '212021-12-31-1.49
Q3 '212021-09-30-16.95
Q2 '212021-06-30-19.87
Q1 '212021-03-31-17.18